95
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Dihydropteroate synthase mutations in Pneumocystis pneumonia: impact of applying different definitions of prophylaxis, mortality endpoints and mutant in a single cohort

, , , , , , , , , , , , , & show all
Pages 568-575 | Received 25 Jul 2012, Accepted 09 Jan 2013, Published online: 08 Mar 2013

References

  • Huang L, Cattamanchi A, Davis JL, et al. HIV-associated Pneumocystis pneumonia. Proc Am Thorac Soc 2011; 8: 294–300.
  • Kazanjian P, Armstrong W, Hossler PA, et al. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J Infect Dis 2000; 182: 551–557.
  • Vedantam G, Nichols BP. Characterization of a mutationally altered dihydropteroate synthase contributing to sulfathiazole resistance in Escherichia coli. Microb Drug Res 1998; 4: 91–97.
  • Lopez P, Espinosa M, Greenberg B, Lacks SA. Sulfonamide resistance in Streptococcus pneumoniae DHPS sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme. J Bacteriol 1987; 169: 4320–4326.
  • Brooks DR, Wang P, Read M, Watkins WM, Sims PFG, Hyde JE. Sequence variation of the hydroxymethyldihydropterin pyrophophokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 1994; 224: 397–405.
  • Moukhlis R, Boyer J, Lacube P, Bolognini J, Roux P, Hennequin C. Linking Pneumocystis jiroveci sulfamethoxazole resistance to the alleles of the DHPS gene using functional complementation in Saccharomyces cerevisiae. Clin Microbiol Infect 2009; 16: 501–507.
  • Iliades P, Meshnick SR, Macreadie IG. Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model. Antimicrob Agents Chemother 2004; 48: 2617–2623.
  • Stein CR, Poole C, Kazanjian P, Meshnick SR. Sulfa use, dihydropteroate synthase mutations and Pneumocystis jirovecii Pneumonia. Emerg Infectious Diseases 2004; 10: 1760–1764.
  • Valerio A, Tronconi E, Mazza F, et al. Genotyping of Pneumocystis jiroveci Pneumonia in Italian AIDS Patients. JAIDS 2007; 45: 521–528.
  • Van Hal SJ, Gilgado F, Doyle T, et al. Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes. J Clin Microbio 2009; 47: 1818–1823.
  • Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 1999; 354: 1347–1351.
  • Navin TR, Beard CB, Huang L, et al. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study. Lancet 2001; 358: 545–549.
  • Crothers K, Beard CB, Turner J, et al. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 2005; 19: 801–805.
  • Beard CB, Carter JL, Keely SP, et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000; 6: 265–272.
  • Kazanjian P, Locke AB, Hossler PA, et al. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 1998; 12: 873–878.
  • Matos O, Esteves . Epidemiology and clinical relevance of Pneumocystis jirovecii. Parasite 2010; 17: 219–232.
  • Latouche S, Lacube P, Maury E, et al. Pneumocystis jirovecii dihydropteroate synthase genotypes in French patients with pneumocystosis: a 1998–2001 prospective study. Med Mycology 2003; 41: 533–537.
  • Esteves F, Gaspar J, Tavares A, Antunes F, Mansinho K, Matos O. Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients. Infect Genet Evol 2010; 19: 192–199.
  • Costa MC, Helweg-Larsen J, Lundgren B, Antunes F, Matos O. Mutations in the dihydropteroate synthase gene of Pneumocystis jiroveci isolates from Portuguese patients with Pneumocystis pneumonia. Intl J Antimicrob Agents 2003; 22: 516–520.
  • Beard CB, Carter JL, Keely SP, et al. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000; 6: 265–272.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.